How Polyproline Type II Conformation at P 2 Residues Influences the Success of Proline-Based Peptidyl Inhibitors Against Coronavirus Main Protease
Biochemistry · 2025
DOI: 10.1021/acs.biochem.4c00437 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemistry, 2025. Verfasst von Pathum Manjula Weerawarna. Beteiligte Einrichtung: Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, Indiana 46202, United States. Hauptthemen laut MEDLINE: Coronavirus 3C Proteases, Proline, SARS-CoV-2, Peptides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, Indiana 46202, United States.
ORCID-Profile: Pathum Manjula Weerawarna
Zitieren
APA
Weerawarna, P. M. (2025). How Polyproline Type II Conformation at P 2 Residues Influences the Success of Proline-Based Peptidyl Inhibitors Against Coronavirus Main Protease. Biochemistry. https://doi.org/10.1021/acs.biochem.4c00437
Vancouver
Weerawarna PM. How Polyproline Type II Conformation at P 2 Residues Influences the Success of Proline-Based Peptidyl Inhibitors Against Coronavirus Main Protease. Biochemistry. 2025. doi:10.1021/acs.biochem.4c00437
BibTeX
@article{Weerawarna2025,
author = {Weerawarna, Pathum Manjula},
title = {How Polyproline Type II Conformation at P 2 Residues Influences the Success of Proline-Based Peptidyl Inhibitors Against Coronavirus Main Protease},
journal = {Biochemistry},
year = {2025},
doi = {10.1021/acs.biochem.4c00437}
}
EUVIMED